Literature DB >> 9493374

Requirement for ubiquinone downstream of cytochrome(s) b in the oxygen-terminated respiratory chains of Escherichia coli K-12 revealed using a null mutant allele of ubiCA.

B Søballe1, R K Poole.   

Abstract

An Escherichia coli knockout ubiCA mutant has been constructed using a gene replacement method and verified using both Southern hybridization and PCR. The mutant, which was unable to synthesize ubiquinone (Q), showed severely diminished growth yields aerobically but not anaerobically with either nitrate or fumarate as terminal electron acceptors. Low oxygen uptake rates were demonstrated in membrane preparations using either NADH or lactate as substrates. However, these rates were greatly stimulated by the addition of ubiquinone-1 (Q-1). The rate of electron transfer to those oxidase components observable by photodissociation of their CO complexes was studied at sub-zero temperatures. In the ubiCA mutant, the reduced form of haemoproteins--predominantly cytochrome b595--was reoxidized significantly faster in the presence of oxygen than in a Ubi+ strain, indicating the absence of Q as electron donor. Continuous multiple-wavelength recordings of the oxidoreduction state of cytochrome(s) b during steady-state respiration showed greater reduction in membranes from the ubiCA mutant than in wildtype membranes. A scheme for the respiratory electron-transfer chain in E. coli is proposed, in which Q functions downstream of cytochrome(s) b.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9493374     DOI: 10.1099/00221287-144-2-361

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  9 in total

1.  Manipulating respiratory levels in Escherichia coli for aerobic formation of reduced chemical products.

Authors:  Jiangfeng Zhu; Ailen Sánchez; George N Bennett; Ka-Yiu San
Journal:  Metab Eng       Date:  2011-10-06       Impact factor: 9.783

2.  Identification of two catalases in Azotobacter vinelandii: a KatG homologue and a novel bacterial cytochrome c catalase, CCCAv.

Authors:  James R Sandercock; William J Page
Journal:  J Bacteriol       Date:  2007-11-30       Impact factor: 3.490

Review 3.  Strategies for manipulation of oxygen utilization by the electron transfer chain in microbes for metabolic engineering purposes.

Authors:  George N Bennett; Ka-Yiu San
Journal:  J Ind Microbiol Biotechnol       Date:  2016-10-31       Impact factor: 3.346

4.  Phospholipid furan fatty acids and ubiquinone-8: lipid biomarkers that may protect dehalococcoides strains from free radicals.

Authors:  David C White; Roland Geyer; Aaron D Peacock; David B Hedrick; Stephen S Koenigsberg; Youlboong Sung; Jianzhong He; Frank E Löffler
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

5.  Detection and quantification of superoxide formed within the periplasm of Escherichia coli.

Authors:  Sergei Korshunov; James A Imlay
Journal:  J Bacteriol       Date:  2006-09       Impact factor: 3.490

6.  Biosynthesis of ubiquinone compounds with conjugated prenyl side chains.

Authors:  Pyung Cheon Lee; Christine Salomon; Benjamin Mijts; Claudia Schmidt-Dannert
Journal:  Appl Environ Microbiol       Date:  2008-09-26       Impact factor: 4.792

7.  Ubiquinone and menaquinone electron carriers represent the yin and yang in the redox regulation of the ArcB sensor kinase.

Authors:  Adrián F Alvarez; Claudia Rodriguez; Dimitris Georgellis
Journal:  J Bacteriol       Date:  2013-05-03       Impact factor: 3.490

8.  Randomly selected suppressor mutations in genes for NADH : quinone oxidoreductase-1, which rescue motility of a Salmonella ubiquinone-biosynthesis mutant strain.

Authors:  Clive S Barker; Irina V Meshcheryakova; Toshio Sasaki; Michael C Roy; Prem Kumar Sinha; Takao Yagi; Fadel A Samatey
Journal:  Microbiology (Reading)       Date:  2014-04-01       Impact factor: 2.777

9.  Kinase activity of ArcB from Escherichia coli is subject to regulation by both ubiquinone and demethylmenaquinone.

Authors:  Poonam Sharma; Stefan Stagge; Martijn Bekker; Katja Bettenbrock; Klaas J Hellingwerf
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.